Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity

Obesity

Volumn 18, Issue 1, 2010, Pages 92-98

  Grassi, Guido ^a,b   Seravalle, Gino ^b   Scopelliti, Francesco ^c   Dell'Oro, Raffaella ^a   Fattori, Luca ^a   Quarti Trevano, Fosca ^a   Brambilla, Gianmaria ^c   Schiffrin, Ernesto L ^d   Mancia, Giuseppe ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; INSULIN; LIPID;

ADULT; ANALYSIS OF VARIANCE; ARTERY; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; MORBID OBESITY; MULTIVARIATE ANALYSIS; MYOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; VASCULAR RESISTANCE; VASODILATATION;

ACETYLCHOLINE; ADULT; ANALYSIS OF VARIANCE; ARTERIES; BLOOD PRESSURE; BODY MASS INDEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOGRAPHY; OBESITY, MORBID; PATIENT SELECTION; VASCULAR RESISTANCE; VASODILATION;

EID: 73949108211     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.195     Document Type: Article

References (40)

1. Ferreira I, Twisk JW, van Mechelen W et al. Current and adolescent body fatness and fat distribution: relationships with carotid intima-media thickness and large artery stiffness at the age of 36 years. J Hypertens 2004;22:145-155.
2. Ferreira I, Snijder MB, Twisk JW et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 2004;89:2632-2639.
3. Ferreira I, Henry RM, Twisk JW et al. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 2005;165:875-882. (Pubitemid 40575728)
4. Zebekakis PE, Nawrot T, Thijs L et al. Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 2005;23:1839-1846.
5. Giltay EJ, Lambert J, Elbers JM et al. Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity only in women. Diabetologia 1999;42:214-221.
6. Mangoni AA, Giannattasio C, Brunani A et al. Radial artery compliance in young, obese, normotensive subjects. Hypertension 1995;26: 984-988.
7. Steinberg HO, Chaker H, Leaming R et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-2610.
8. Levy BI, Schiffrin EL, Mourad JJ et al. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 2008;118:968-976.
9. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187. (Pubitemid 46924065)
10. Rizzoni D, Porteri E, Boari GE et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003;108:2230-2235.
11. Mathiassen ON, Buus NH, Sihm I et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007;25:1021-1026.
12. De Ciuceis C, Porteri E, Rizzoni D et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 2007;20:846-852.
13. Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999;33:569-574
14. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22: 667-689.
15. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-618.
17. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
18. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000;101:1653-1659.
19. Savoia C, Touyz RM, Endemann DH et al. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Hypertension 2006;48:271-277.
20. Rizzoni D, Porteri E, Guelfi D et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001;103:1238-1244. (Pubitemid 32221346)
21. Endemann DH, Pu Q, De Ciuceis C et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004;43:399-404.
22. Savoia C, Touyz RM, Amiri F, Schiffrin EL. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients. Hypertension 2008;51:432-439.
23. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000;36:312-318.
24. Aalkjaer C, Pedersen EB, Danielsen H et al. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci 1986;71:657-663.
25. Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005;23:247-250.
26. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002;106:3037-3043.
27. Goode GK, Heagerty AM. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995;91:2898-2903.
28. Cooper A, Heagerty AM. Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia. Am J Physiol 1998;275:H1482-H1488.
29. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2276-2283.
30. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997;96:4104-4113.
31. Grassi G, Seravalle G, Cattaneo BM et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995;25:560-563.
32. Grassi G, Seravalle G, Dell'Oro R et al. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000;36:538-542.
33. Grassi G, Dell'Oro R, Facchini A et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004;22:2363-2369.
34. Alvarez GE, Beske SD, Ballard T P, Davy K P. Sympathetic neural activation in visceral obesity. Circulation 2002;106:2533-2536.
35. Grassi G. Counteracting the sympathetic nervous system in essential hypertension. Curr Opin Nephrol Hypertens 2004;13:513-519. (Pubitemid 39150077)
36. Knudson JD, Payne GA, Borbouse L, Tune JD. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep 2008;10:434-439.
37. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006;30:400-418.
38. Schiffrin EL, Hayoz D. How to assess vascular remodelling in small and medium-sized muscular arteries in humans. J Hypertens 1997;15:571-584.
39. de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004;109:2529-2535. (Pubitemid 38720552)
40. Rizzoni D, Palombo C, Porteri E et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003;21:625-631.